ENTRY       D11293                      Drug
NAME        Gosuranemab (USAN);
            Gosuranemab (genetical recombination) (JAN)
FORMULA     C6434H9930N1706O2014S48
EXACT_MASS  144853.3643
MOL_WEIGHT  144943.0298
SEQUENCE    (Heavy chain)
            EVHLVESGGA LVKPGGSLRL SCAASGFSFS KYGMSWVRQA PGKGLEWVAT ISSSGSRTYY
            PDSVKGRFTI SRDNAKNTLY LQMNSLRAED TAMYYCSISW DGAMDYWGQG TTVTVSSAST
            KGPSVFPLAP CSRSTSESTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTKTYTC NVDHKPSNTK VDKRVESKYG PPCPPCPAPE FLGGPSVFLF
            PPKPKDTLMI SRTPEVTCVV VDVSQEDPEV QFNWYVDGVE VHNAKTKPRE EQFNSTYRVV
            SVLTVLHQDW LNGKEYKCKV SNKGLPSSIE KTISKAKGQP REPQVYTLPP SQEEMTKNQV
            SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSRLTVD KSRWQEGNVF
            SCSVMHEALH NHYTQKSLSL SLGK
            (Light chain)
            DVVMTQSPLS LPVTLGQPAS ISCKSSQSIV HSNGNTYLEW YLQKPGQSPQ LLVYKVSNRF
            SGVPDRFSGS GSGTDFTLKI SRVEAEDVGT YYCFQGSLVP WAFGGGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H96, H131-L219, H144-H200, H223-H'223, H226-H'226, H258-H318, H364-H422, H'22-H'96, H'131-L'219, H'144-H'200, H'258-H'318, H'364-H'422, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  TYPE      Peptide
EFFICACY    Anti-tau protein antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of progressive supranuclear palsy (PSP) and other tauopathies
TARGET      MAPT (TAU) [HSA:4137] [KO:K04380]
  PATHWAY   hsa04010(4137)  MAPK signaling pathway
            hsa05010(4137)  Alzheimer disease
            hsa05022(4137)  Pathways of neurodegeneration - multiple diseases
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Cellular process
               Cytoskeleton
                MAPT (TAU)
                 D11293  Gosuranemab (USAN)
DBLINKS     CAS: 1788032-39-2
            PubChem: 384585271
///
